Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Coya Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 164K | Jun 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
COYA | Coya Therapeutics, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Chief Executive Officer, Director |
COYA | Coya Therapeutics, Inc. | Jan 31, 2024 | 1 | $0 | 4 | Feb 2, 2024 | Chief Executive Officer, Director |
COYA | Coya Therapeutics, Inc. | Feb 27, 2023 | 1 | $0 | 4 | Mar 1, 2023 | Chief Executive Officer, Director |
COYA | Coya Therapeutics, Inc. | Jan 3, 2023 | 0 | $0 | 4/A | Jan 17, 2023 | Chief Executive Officer, Director, 10%+ Owner |
COYA | Coya Therapeutics, Inc. | Dec 28, 2022 | 0 | $0 | 3 | Dec 28, 2022 | Chief Executive Officer, Director, 10%+ Owner |